ETHYL 3-OXOTETRAHYDRO-2H-PYRAN-4-CARBOXYLATE, 95.0%, 250mg

5H-Pyrrolo[3,4-b]pyridin-7(6H)-one, 95.0%, 5g

(R)-Morpholin-3-ylmethanol hydrochloride, 95.0%, 10g

2-Hydrazinyl-3-methoxypyridine, 97%, 10g

2,3-Dihydro-benzo[1,4]dioxine-2-carboxylic acid methyl ester, 95.0%, 5g

Tetrabutylammonium Perchlorate>98.0%(T)100g

N-(4-fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)pyrimidin-2-amine hydrochloride, 98%, 250mg

5-ETHYL-2-FLUOROBENZALDEHYDE, 95%, 500mg

5-(5,5-dimethyl-1,3-dioxan-2-yl)-3',5'-dimethyl-4'-methoxyvalerophenone, 97.0%, 1g

Ammonium hydrogen carbonate, min. 98%, Ph.Eur., BP, 2.5 kg, plastic packaging.

1,2-Ethanediamine, N1-methyl-N1-[[4-[4-(1-methylethoxy)phenyl]-1H-pyrrol-3-yl]methyl]-, 98%, 5mg

(S)-2-Benzyl-2,3-dihydrobenzo[d]imidazo[2,1-b]thiazole, 97%, 100mg

Transfer membrane ROTI®PVDF 0.45